Cyprus’s Oncology Pharmaceutical Export: The Export Market Insights of 2024

Oncology Pharmaceuticals is the category of medications that are used in healthcare facilities for diagnosing and treating cancer diseases. These drugs are a preference of the top global traders because they stop cancer cell growth and reduces symptoms caused by tumours. Due to the unequal production capacity in different countries worldwide, along with the higher global demand, the overall trade of oncology drugs globally has increased. Cyprus Import Data says that the country, with its advanced pharmaceutical manufacturing capacity and strong ability to produce high-value oncology formulations, has recorded a gradual increase in its oncology drug exports.

The specific commodity accounts for almost 27% of the pharma exports of Cyprus, totalling a valuation of 219 million US dollars in 2024. The supportive government policies and the compliance with international export standards have benefited the overall revenue. Subscribe to Import Globals, the leading Cyprus import export trade provider, to stay updated with the latest information regarding the pharmaceutical export of the nation via the Cyprus trade data.

IMPACTS OF NATIONAL STRATEGIES ON CYPRUS'S ONCOLOGY PHARMACEUTICALS EXPORT 

The tax incentives for high-tech pharmaceutical manufacturers have reduced the overall production cost. It has allowed the export of oncology drugs to remain price-competitive. The alignment with the EU and international quality and regulatory framework has boosted the global confidence of Cyprus. It has expanded the market access while accelerating the import approvals. 

The funding and grants for pharmaceutical R&D and clinical innovation have encouraged the development of advanced oncology formulations. It has attracted international licensing deals. The trade promotion and export facilitation programs have resulted in a wider global customer base. The support for direct investment in life sciences and pharma manufacturing has attracted multinational pharmaceutical companies for the establishment of production and packaging units. It has basically increased the export capacity and positioning of the country. 

THE LEADING VARIANTS OF ONCOLOGY PHARMACEUTICALS EXPORTED FROM CYPRUS IN 2024

Due to the highly developed shipping and maritime connections and the collaborations between pharmaceutical companies and universities, the country has recorded diversity in its global trade output. As per the Cyprus Export Data, the top 10 leading variants of oncology pharmaceuticals exported from the nation in 2024 are,

  1. Paclitaxel – The annual valuation of Paclitaxel exported from Cyprus in 2024 – 87 million US dollars
  2. Doxorubicin – The annual valuation of Doxorubicin exported from Cyprus in 2024 – 62 million US dollars
  3. Fluorouracil (5-FU) – The annual valuation of Fluorouracil exported from Cyprus in 2024 – 41 million US dollars
  4. Vincristine – The annual valuation of Vincristine exported from Cyprus in 2024 – 39 million US dollars
  5. Dacarbazine– The annual valuation of Dacarbazine exported from Cyprus in 2024 – 28 million US dollars
  6. Bevacizumab– The annual valuation of Bevacizumab exported from Cyprus in 2024 – 26 million US dollars
  7. Pembrolizumab– The annual valuation of Pembrolizumab exported from Cyprus in 2024 – 24 million US dollars
  8. Nivolumab– The annual valuation of Nivolumab exported from Cyprus in 2024 – 22 million US dollars
  9. Durvalumab– The annual valuation of Durvalumab exported from Cyprus in 2024 – 18 million US dollars
  10. Dostarlimab– The annual valuation of Dostarlimab exported from Cyprus in 2024 – 10 million US dollars

TOP 10 EXPORT TRADE PARTNERS OF CYPRUS IN 2024

The clinical evolution of the infrastructure related to foreign pharma partnerships and the rising global cancer incidence has prompted the country to build a stable trade relationship with the topmost importing nations for neutralizing the risk rate. According to the Cyprus Customs Data, the top 10 export trade partners of the nation for oncology pharmaceuticals exports in 2024 are,

  • Libya – The total valuation of oncology pharmaceuticals exported from Cyprus to Libya in 2024 – 79 million US dollars
  • Top 5 variants of oncology pharmaceuticals exported
  1. Docetaxel
  2. Doxorubicin
  3. Epirubicin
  4. Daunorubicin
  5. Idarubicin
  • Lebanon– The total valuation of oncology pharmaceuticals exported from Cyprus to Lebanon in 2024 – 64 million US dollars
  • Top 5 variants of oncology pharmaceuticals exported
  1. Cyclophosphamide
  2. Ifosfamide
  3. Melphalan
  4. Bendamustine
  5. Busulfan
  • Bermuda– The total valuation of oncology pharmaceuticals exported from Cyprus to Bermuda in 2024 –40 million US dollars
  • Top 5 variants of oncology pharmaceuticals exported
  1. Carmustine
  2. Lomustine
  3. Chlorambucil
  4. Cisplatin
  5. Carboplatin
  • Greece – The total valuation of oncology pharmaceuticals exported from Cyprus to Greece in 2024 – 35 million US dollars
  • Top 5 variants of oncology pharmaceuticals exported
  1. Oxaliplatin
  2. Fluorouracil (5-FU)
  3. Capecitabine
  4. Gemcitabine
  5. Cytarabine
  • Marshall Islands – The total valuation of oncology pharmaceuticals exported from Cyprus to Marshall Islands in 2024 – 29 million US dollars
  • Top 5 variants of oncology pharmaceuticals exported
  1. Methotrexate
  2. Pemetrexed
  3. Pralatrexate
  4. Vincristine
  5. Vinblastine
  • United Kingdom – The total valuation of oncology pharmaceuticals exported from Cyprus to United Kingdom in 2024 – 23 million US dollars
  • Top 5 variants of oncology pharmaceuticals exported
  1. Vinorelbine
  2. Etoposide
  3. Teniposide
  4. Irinotecan
  5. Topotecan
  • Liberia – The total valuation of oncology pharmaceuticals exported from Cyprus to Liberia in 2024 – 18 million US dollars
  • Top 5 variants of oncology pharmaceuticals exported
  1. Mitoxantrone
  2. Thiotepa
  3. Tretinoin (ATRA)
  4. Arsenic trioxide
  5. Temozolomide
  • Hong Kong– The total valuation of oncology pharmaceuticals exported from Cyprus to Hong Kong in 2024 – 16 million US dollars
  • Top 5 variants of oncology pharmaceuticals exported
  1. Procarbazine
  2. Bleomycin
  3. Pegaspargase
  4. Asparaginase
  5. Hydroxyurea
  • Nigeria– The total valuation of oncology pharmaceuticals exported from Cyprus to Nigeria in 2024 – 12 million US dollars
  • Top 5 variants of oncology pharmaceuticals exported
  1. Alemtuzumab
  2. Rituximab
  3. Obinutuzumab
  4. Ofatumumab
  5. Cetuximab
  • United States– The total valuation of oncology pharmaceuticals exported from Cyprus to United States in 2024 – 10 million US dollars
  • Top 5 variants of oncology pharmaceuticals exported
  1. Ramucirumab
  2. Pembrolizumab
  3. Nivolumab
  4. CemiplimabDurvalumab

Comments

Popular posts from this blog

Overview of the Optical Equipment Import of Vietnam in 2023

An in-depth Analysis of Gold, Nicaragua's Top Export

Seafood Export of Uganda in 2023